Clinical Trials in Connecticut (CT)
Are you looking to enroll in a clinical trial in Connecticut? With new trials like "A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)" and "Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years", the Constitution State has established itself as a great location for clinical research studies, particularly in cities like Aurora and Denver.
While some individuals are looking for paid clinical trials, others want to help advance cardiology and toxicology clinical research in Connecticut. To begin your search for Connecticut clinical trials, use the form on the right.